Polifarma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 296,488 | 250,838 | 260,139 | 294,754 | 291,463 | 297,693 | 683,139 | 547,814 |
| Profit before tax | 179,463 | - | - | - | - | - | - | 275,499 |
| Net profit | 170,477 | 136,799 | 168,606 | 183,728 | 130,914 | 121,306 | 320,029 | 231,743 |
| Equity | 584,387 | 684,917 | 868,215 | 1,050,347 | 1,181,261 | 1,302,567 | 1,420,028 | 1,331,744 |
| Liabilities | 114,885 | 33,721 | 30,303 | 304,142 | 612,143 | 476,772 | 499,650 | 2,001,353 |
| Non-current assets | 317,297 | 438,664 | 322,059 | 300,534 | 1,341,889 | 1,380,935 | 1,534,877 | 1,532,859 |
| Current assets | 381,975 | 279,974 | 576,459 | 1,053,955 | 451,515 | 398,404 | 384,229 | 1,799,988 |
| Total assets | 699,272 | 718,638 | 898,518 | 1,354,489 | 1,793,404 | 1,779,339 | 1,919,106 | 3,332,847 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 64,988 | 95,767 | 203,236 |
| Social insurance contributions | - | - | - | - | - | 13,613 | 12,756 | 13,911 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.1% | -15.4% | +3.7% | +13.3% | -1.1% | +2.1% | +129.5% | -19.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 24.4% | 19.0% | 18.8% | 13.6% | 7.3% | 6.8% | 16.7% | 7.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 29.2% | 20.0% | 19.4% | 17.5% | 11.1% | 9.3% | 22.5% | 17.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 57.5% | 54.5% | 64.8% | 62.3% | 44.9% | 40.7% | 46.8% | 42.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 60.5% | - | - | - | - | - | - | 50.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.0 | 0.0 | 0.3 | 0.5 | 0.4 | 0.4 | 1.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 32,943 | 26,174 | 35,881 | 41,613 | 51,434 | 60,547 | 136,628 | 136,954 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Polifarma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-03-03 | 2025-03-03 | 220.90 |
| 2025-02-18 | 2025-02-26 | 220.90 |
| 2025-01-22 | 2025-01-22 | 2.64 |
| 2023-09-18 | 2023-09-18 | 1144.27 |
| 2023-06-16 | 2023-07-16 | 0.38 |
| 2023-05-16 | 2023-06-15 | 3.15 |
| 2023-05-02 | 2023-05-14 | 3.15 |
| 2023-04-18 | 2023-04-28 | 3.15 |
| 2023-03-16 | 2023-04-13 | 3.15 |
| 2023-02-17 | 2023-03-13 | 3.15 |
| 2023-02-06 | 2023-02-12 | 3.15 |
| 2023-01-24 | 2023-02-03 | 3.15 |
| 2023-01-23 | 2023-01-23 | 2.75 |
| 2023-01-20 | 2023-01-22 | 3.15 |
| 2023-01-17 | 2023-01-19 | 2.75 |
| 2022-12-16 | 2023-01-10 | 2.75 |
| 2022-11-21 | 2022-12-14 | 2.75 |
| 2022-11-17 | 2022-11-18 | 2.75 |
| 2022-09-16 | 2022-11-13 | 2.75 |
| 2022-08-23 | 2022-09-11 | 2.75 |
| 2022-07-25 | 2022-08-11 | 2.97 |
| 2022-07-18 | 2022-07-24 | 0.37 |
| 2022-05-17 | 2022-07-12 | 0.37 |
| 2022-04-28 | 2022-05-12 | 0.37 |
| 2022-04-19 | 2022-04-20 | 601.25 |
| 2022-03-16 | 2022-04-18 | 0.19 |
| 2022-02-17 | 2022-03-14 | 0.19 |
| 2022-01-31 | 2022-02-13 | 0.19 |
| 2022-01-18 | 2022-01-18 | 1037.86 |
| 2021-12-20 | 2021-12-26 | 78.49 |
| 2021-12-16 | 2021-12-19 | 52.07 |
Polifarma - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-01 | 2025-05-06 | 143.1 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Polifarma, UAB (code 304110874) is a Private Limited Liability Company engaged in the wholesale of other food. In 2025, the company generated revenue of €547.8K and net profit of €231.7K, resulting in a profit margin of 42.3%. Revenue decreased by 19.8% year on year from 2024, but remained 84.0% above the 2023 level of €297.7K, showing strong two-year expansion followed by a partial correction in the latest year. Net profit also developed positively over the period, rising from €121.3K in 2023 to €320.0K in 2024 before easing in 2025. The 2025 balance sheet strengthened significantly, with total assets of €3.33M, equity of €1.33M and liabilities of €2.00M. The equity ratio stood at 40.0% and debt-to-equity at 1.50, indicating a leveraged but still balanced capital structure. Return on equity was 17.4% and return on assets 7.0%. Asset turnover remained modest at 0.16x. Revenue per employee reached €137.0K, while profit per employee was €57.9K.